Cadre Holdings (CDRE) is a Jacksonville, Florida-based manufacturer and distributor of mission-critical safety and survivorship equipment — body armor, duty gear, holsters, explosive ordnance disposal gear and nuclear safety products — sold largely under the Safariland and Med-Eng brands to law enforcement, first responders, the military and nuclear operators. Shares traded at $31.39 on Monday, down 6.07% from the prior session's close of $33.42, confirming a decisive move lower. The immediate trigger was a pre-market corporate release disclosing the departure of the company's chief financial officer at year-end, layered on top of a tape that was broadly weaker and a stock that had already run hard over the previous five weeks.
In a release published before the opening bell, Cadre said CFO Blaine Browers will leave at the end of 2026 to become finance chief at a diversified, large-cap manufacturer of engineered critical components. Chad Appleby, who has served as vice president and treasurer since 2014, takes over on an interim basis while the company searches for a permanent successor. Management reaffirmed its previously issued 2026 guidance of $756 million to $769 million in net sales and $140 million to $144 million in adjusted EBITDA.
That reaffirmation matters, because it caps the downside narrative: the news is a leadership transition, not a financial shortfall. But Cadre is a serial acquirer with a heavier balance sheet than a year ago — net debt stood at $305.6 million at the end of the third quarter — and the CFO is the architect of that deal machine. Investors typically apply a modest discount to an acquirer losing its finance chief mid-integration, particularly when a first-ever $100 million buyback program, authorized only two weeks ago, still needs execution.
The larger mechanical driver was positioning. Cadre closed at $24.55 on October 9 and reached $34.79 intraday on November 12 — a gain of roughly 42% in about five weeks — after strong third-quarter results, a second consecutive guidance raise and the buyback authorization. That left the stock extended and vulnerable. Today's decline simply retraces part of that advance and pulls the shares back toward their 20-day moving average near $31, a level the stock is now testing. The 50-day average, near $28.30, remains intact, so the medium-term uptrend has not been broken.
Cadre's decline was not a sector event. The broad tape was softer, with the S&P 500 off 1.26% and small caps down 0.93%, and the industrials and aerospace-defense ETFs shed less than 1% each. Against that backdrop, Cadre's 6.07% drop represents roughly five percentage points of company-specific underperformance — a clear signal that the CFO announcement, not macro sentiment, did the work.
Liquidity is a relevant factor. Average daily volume over three months is approximately 450,000 shares, and recent sessions have ranged from about 250,000 to 600,000 shares, with a market capitalization of roughly $1.35 billion. On a float of that size, a single institutional seller reacting to a management change can move the tape meaningfully. The stock is also far below its 52-week high of $48.76 and well above its low of $24.07.
The scale runs from 0 — no meaningful news and a move that is normal for the stock — to 100, meaning transformative news accompanied by an extreme, rare price move. This event lands at 30 out of 100.
The verified news is genuinely modest: a CFO resignation with an internal interim replacement, and guidance explicitly reaffirmed. It is material to sentiment but carries no change to earnings expectations. The price move, by contrast, was about 3.4 times Cadre's typical absolute daily move of roughly 1.8% over the past 60 sessions, and only one session in that window produced a larger swing. Two moderate inputs combine into a moderate score — real but hardly transformative news driving a notable, though not unprecedented, decline.
Attention now turns to the permanent CFO search and the company's fourth-quarter report, expected in early March 2027, which will be the first test of management's reaffirmed full-year targets and its initial 2027 commentary. Investors will also parse order backlog trends after a sequential decline of roughly $29 million in the third quarter, integration progress on the Tier Tactical and AlienGear acquisitions, and whether leverage stabilizes near 2.2 times. Sector developments — international public safety budgets, nuclear infrastructure investment and the pace of the acquisition pipeline — remain the structural swing factors. The principal risks are execution on integrations, margin pressure from acquired lower-margin businesses, and the possibility that leadership turnover slows deal-making.
Tickeron maintains hundreds of AI trading bots covering thousands of tickers, and the Trending AI Robots page curates only those posting the strongest performance under current market conditions. Bots differ widely by strategy, timeframe, tracked performance metrics and the symbols they trade, so the list rotates as market regimes shift. Reviewing it can help traders see which automated approaches are working right now — worth a look before positioning around volatility like today's.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CDRE saw its Momentum Indicator move above the 0 level on October 13, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned positive. In 71 of the 83 cases, the stock moved higher in the following days. The odds of a move higher are at 86%.
CDRE moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CDRE crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 18 of 24 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
Following a +5.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where CDRE advanced for three days, in 255 of 321 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 214 of 289 cases where CDRE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.
The 10-day RSI Indicator for CDRE moved out of overbought territory on November 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 30 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 73%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 22 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CDRE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
CDRE broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. CDRE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 49 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.025) is normal, around the industry mean (5.050). P/E Ratio (37.907) is within average values for comparable stocks, (17.247). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.110). Dividend Yield (0.012) settles around the average of (0.055) among similar stocks. P/S Ratio (1.720) is also within normal values, averaging (18.367).
The Tickeron SMR rating for this company is 68 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CDRE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AerospaceDefense